Thalidomide therapy for cicatricial pemphigoid

Cicatricial pemphigoid is a chronic, presumed autoimmune, blistering disease of the mucous membranes and occasionally of the skin. The characteristic feature is scarring at the sites of healing. We report the use of thalidomide as a therapeutic agent to control previously resistant disease. (J Am Ac...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of the American Academy of Dermatology 2002-08, Vol.47 (2), p.S193-S195
Hauptverfasser:	Duong, Daihung Jay, Moxley, Richard T., Kellman, Robert M., Pincus, Stephanie H., Gaspari, Anthony A.
Format:	Artikel
Sprache:	eng
Schlagworte:	Aged Anti-Inflammatory Agents, Non-Steroidal - therapeutic use Biological and medical sciences Dapsone - therapeutic use Dermatologic Agents - administration & dosage Dermatologic Agents - therapeutic use Humans Immunosuppressive Agents - administration & dosage Immunosuppressive Agents - therapeutic use Laryngeal Diseases - drug therapy Male Medical sciences Pemphigoid, Benign Mucous Membrane - drug therapy Pharmacology. Drug treatments Pharyngeal Diseases - drug therapy Skin, nail, hair, dermoskeleton Thalidomide - administration & dosage Thalidomide - therapeutic use
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Cicatricial pemphigoid is a chronic, presumed autoimmune, blistering disease of the mucous membranes and occasionally of the skin. The characteristic feature is scarring at the sites of healing. We report the use of thalidomide as a therapeutic agent to control previously resistant disease. (J Am Acad Dermatol 2002;47:S193-5).
ISSN:	0190-9622 1097-6787
DOI:	10.1067/mjd.2002.109255